L-Nutra lands $47m to advance longevity nutrition tech

L-Nutra lands $47m to advance longevity nutrition tech

Longevity.Technology is growing fast; we are open to conversations with prospective partners and investors who share our vision.

Please get in touch if you are interested:

Moderna CEO leads new investment in company developing longevity science nutrition programs.

Nutri-technology company L-Nutra has successfully closed the first stage of its Series D fundraising, securing a total of $47 million. The company specializes in longevity science nutrition programs designed to promote healthy living and longevity.

Create a free account to read this article now

Join the 12,000+ biotech, pharma and investment leaders who read Longevity.Technology. No password, no payment.

By continuing you agree to our Terms and Privacy Policy, and to receive the free Longevity.Technology newsletter. You can unsubscribe at any time.

LTUI: 2536

L-Nutra

Longevity level(s):

  • Level 3: Longevity biohacking
    Companies that manufacture ingredients and dietary supplements, or produce equipment such as red light therapy, cryonic chambers, and enhanced exercise equipment to maintain the metabolism and replace cellular function lost with the progression of age.
  • Level 4: Longevity clinical services
    Professionally qualified clinics that offer diagnosis of health and aging biomarkers; clinical guidance on lifestyle, diet and therapeutic interventions to mitigate the progression of age.
  • Level 6: Aging disease prevention therapeutics
    Therapeutic interventions that control aging drivers to prevent aging diseases from occurring, like the current wave of GLP-1 agonists that prevent type 2 diabetes through metabolic interventions that also are proving effective in mitigating cardiovascular and neurological diseases.

Overview

L-Nutra is a nutrition technology company pioneering the discovery, design, and commercialization of plant-based nutrition programs and therapeutics targeting cellular aging and chronic metabolic disease. The company develops fasting-mimicking diet formulations and interventional nutrition therapies designed to activate cellular rejuvenation mechanisms including autophagy and cellular reprogramming. L-Nutra operates across consumer wellness and clinical care divisions, with its flagship product Prolon and medical division L-Nutra Health focused on metabolic health restoration and disease remission. Supported by 47 clinical trials and 137 granted patents, the company aims to redefine nutrition as a primary therapeutic modality for extending healthspan and preventing age-related disease.

Access all data points on DLT:

  • Financial Data
  • Patents
  • Technology
  • Management
  • Advisory Board
  • News
  • Classifications
  • Similar Companies
Expand

Danny Sullivan

Danny has worked in technology communications for more than 20 years, and has been writing about developments the longevity sector since 2019. With a keen interest in the transfer of technology to market, he focuses primarily on the companies working on cutting-edge solutions to aging and age-related diseases.

Sign up for our daily newsletter to get our biggest longevity stories, handpicked for you each day.

Oyster surfaces with $60m and a tau degrader that travels light

The latest longevity science, investment, innovation and insight, delivered every morning.

Unlock Longevity Biotech Report for FREE